.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Cipla
Fuji
McKesson
Dow
Deloitte
UBS
Medtronic
AstraZeneca

Generated: December 12, 2017

DrugPatentWatch Database Preview

Butoconazole nitrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for butoconazole nitrate and what is the scope of butoconazole nitrate freedom to operate?

Butoconazole nitrate
is the generic ingredient in four branded drugs marketed by Perrigo Pharma Intl, Roche Palo, Bayer, and Perrigo Israel, and is included in five NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Butoconazole nitrate has fourteen patent family members in ten countries.

There are six drug master file entries for butoconazole nitrate. One supplier is listed for this compound.

Summary for butoconazole nitrate

Pharmacology for butoconazole nitrate

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Roche PaloFEMSTATbutoconazole nitrateCREAM;VAGINAL019215-001Nov 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BayerFEMSTAT 3butoconazole nitrateCREAM;VAGINAL020421-001Dec 21, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Perrigo Pharma IntlBUTOCONAZOLE NITRATEbutoconazole nitrateCREAM;VAGINAL019881-001Feb 7, 1997DISCNNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Perrigo IsraelGYNAZOLE-1butoconazole nitrateCREAM;VAGINAL200923-001May 18, 2012RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Roche PaloFEMSTATbutoconazole nitrateSUPPOSITORY;VAGINAL019359-001Nov 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: butoconazole nitrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche PaloFEMSTATbutoconazole nitrateSUPPOSITORY;VAGINAL019359-001Nov 25, 1985► Subscribe► Subscribe
Perrigo Pharma IntlBUTOCONAZOLE NITRATEbutoconazole nitrateCREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
BayerFEMSTAT 3butoconazole nitrateCREAM;VAGINAL020421-001Dec 21, 1995► Subscribe► Subscribe
Perrigo Pharma IntlBUTOCONAZOLE NITRATEbutoconazole nitrateCREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
Roche PaloFEMSTATbutoconazole nitrateCREAM;VAGINAL019215-001Nov 25, 1985► Subscribe► Subscribe
Perrigo Pharma IntlBUTOCONAZOLE NITRATEbutoconazole nitrateCREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
Perrigo Pharma IntlBUTOCONAZOLE NITRATEbutoconazole nitrateCREAM;VAGINAL019881-001Feb 7, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: butoconazole nitrate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,416,778 Pharmaceutical preparations and methods for their regional administration► Subscribe
6,652,874 Pharmaceutical preparations and methods for their regional administration► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: butoconazole nitrate

Country Document Number Estimated Expiration
European Patent Office2316424► Subscribe
Japan2010138196► Subscribe
Denmark0977555► Subscribe
Japan2001511773► Subscribe
Canada2278541► Subscribe
Austria321532► Subscribe
Portugal977555► Subscribe
Australia743157► Subscribe
Spain2260828► Subscribe
European Patent Office0977555► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Accenture
UBS
Farmers Insurance
Covington
Argus Health
Julphar
Daiichi Sankyo
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot